Cargando…

Nebulised dornase alfa versus placebo or hypertonic saline in adult critically ill patients: a systematic review of randomised clinical trials with meta-analysis and trial sequential analysis

BACKGROUND: Nebulised dornase alfa is used off-label in critically ill patients. We aimed to assess the benefits and harms of nebulised dornase alfa versus placebo, no prophylaxis, or hypertonic saline on patient-important outcome measures in adult critically ill patients. METHODS: We performed a sy...

Descripción completa

Detalles Bibliográficos
Autores principales:	Claudius, Casper, Perner, Anders, Møller, Morten Hylander
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2015
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4637143/ https://www.ncbi.nlm.nih.gov/pubmed/26547839 http://dx.doi.org/10.1186/s13643-015-0142-z

Ejemplares similares

Acetate‐ versus lactate‐buffered crystalloid solutions: A systematic review with meta‐analysis and trial sequential analysis
por: Ellekjaer, Karen Louise, et al.
Publicado: (2022)

The use of dornase alfa in patients with COVID-19
por: Ramachandram, Dinesh Sangarran, et al.
Publicado: (2023)

SABRE: a multicentre randomised control trial of nebulised hypertonic saline in infants hospitalised with acute bronchiolitis
por: Everard, Mark L, et al.
Publicado: (2014)

Comparison of nebulised 3% hypertonic saline with ipratropium bromide in treatment of children with bronchiolitis: a randomized control trial
por: Naveed, Hina, et al.
Publicado: (2023)

Stress ulcer prophylaxis versus placebo or no prophylaxis in adult hospitalised acutely ill patients—protocol for a systematic review with meta-analysis and trial sequential analysis
por: Marker, Søren, et al.
Publicado: (2017)

Aerosol Delivery of Dornase Alfa Generated by Jet and Mesh Nebulizers
por: Chang, Kyung Hwa, et al.
Publicado: (2020)

Non-Randomized Trial of Dornase Alfa for Acute Respiratory Distress Syndrome Secondary to Covid-19
por: Holliday, Zachary M., et al.
Publicado: (2021)

Nebulised hypertonic saline (3 %) among children with mild to moderately severe bronchiolitis - a double blind randomized controlled trial
por: Khanal, Aayush, et al.
Publicado: (2015)

Nebulised 3% hypertonic saline versus 0.9% saline for treating patients hospitalised with acute bronchiolitis: protocol for a randomised, double-blind, multicentre trial
por: Szupieńko, Sara, et al.
Publicado: (2023)

Consideration of dornase alfa for the treatment of severe COVID-19 acute respiratory distress syndrome
por: Earhart, A.P., et al.
Publicado: (2020)

The Use of Dornase Alfa in the Management of COVID-19-Associated Adult Respiratory Distress Syndrome
por: Toma, Andrew, et al.
Publicado: (2021)

Dornase alfa in Cystic Fibrosis: indications, comparative studies and effects on lung clearance index
por: Terlizzi, Vito, et al.
Publicado: (2022)

Preliminary report of in vitro and in vivo effectiveness of dornase alfa on SARS-CoV-2 infection
por: Okur, H.K., et al.
Publicado: (2020)

The effect of blinding on estimates of mortality in randomised clinical trials of intensive care interventions: protocol for a systematic review and meta-analysis
por: Anthon, Carl Thomas, et al.
Publicado: (2017)

Protocol for TRAUMADORNASE: a prospective, randomized, multicentre, double-blinded, placebo-controlled clinical trial of aerosolized dornase alfa to reduce the incidence of moderate-to-severe hypoxaemia in ventilated trauma patients
por: Pottecher, Julien, et al.
Publicado: (2020)

The added value of hypertonic saline solution to furosemide monotherapy in patients with acute decompensated heart failure: A meta‐analysis and trial sequential analysis
por: Diaz‐Arocutipa, Carlos, et al.
Publicado: (2023)

Use of dornase alfa in the paediatric intensive care unit: current literature and a national cross-sectional survey
por: den Hollander, Bibiche, et al.
Publicado: (2022)

Predictive Performance of the Simplified Acute Physiology Score (SAPS) II and the Initial Sequential Organ Failure Assessment (SOFA) Score in Acutely Ill Intensive Care Patients: Post-Hoc Analyses of the SUP-ICU Inception Cohort Study
por: Granholm, Anders, et al.
Publicado: (2016)

Lidocaine coinfusion alleviates vascular pain induced by hypertonic saline infusion: a randomized, placebo-controlled trial
por: Song, Zhiping, et al.
Publicado: (2021)

Exploratory study of the effectiveness of nebulised saline in children with neurodisability
por: Galaz Souza, Natalia, et al.
Publicado: (2021)

Nebulized in-line endotracheal dornase alfa and albuterol administered to mechanically ventilated COVID-19 patients: a case series
por: Weber, Andrew G., et al.
Publicado: (2020)

Nebulized in-line endotracheal dornase alfa and albuterol administered to mechanically ventilated COVID-19 patients: A case series
por: Weber, Andrew G., et al.
Publicado: (2020)

Effect of Dornase Alfa on the Lung Clearance Index in Children with Cystic Fibrosis: A Lesson from a Case Series
por: Terlizzi, Vito, et al.
Publicado: (2022)

Nebulised magnesium sulphate as an adjuvant to the treatment of acute exacerbation of COPD: A systematic review and meta-analysis of randomised controlled trials with trial sequential analysis
por: Datta, Priyankar Kumar, et al.
Publicado: (2023)

ROC trials update on prehospital hypertonic saline resuscitation in the aftermath of the US-Canadian trials
por: Dubick, Michael A, et al.
Publicado: (2013)

Untargeted antifungal therapy in adult patients with complicated intra-abdominal infection: protocol for a systematic review with meta-analysis
por: Petersen, Marie Warrer, et al.
Publicado: (2017)

Intrapleural Tissue Plasminogen Activator and Dornase Alfa Administration for a Multiloculated Recurrent Malignant Pleural Effusion: A Case Report
por: Nikoomanesh, Kia, et al.
Publicado: (2022)

Hypertonic saline resuscitation in sepsis
por: Wade, Charles E
Publicado: (2002)

Hypertonic Saline in Snake-Bite
por: Bhattacharyya, R. K.
Publicado: (1928)

Stress ulcer prophylaxis with a proton pump inhibitor versus placebo in critically ill patients (SUP-ICU trial): study protocol for a randomised controlled trial
por: Krag, Mette, et al.
Publicado: (2016)

Lower vs Higher Fluid Volumes in Adult Patients With Sepsis: An Updated Systematic Review With Meta-Analysis and Trial Sequential Analysis
por: Sivapalan, Praleene, et al.
Publicado: (2023)

Conservative vs. liberal fluid therapy in septic shock – Protocol for secondary Bayesian analyses of the CLASSIC trial
por: Sivapalan, Praleene, et al.
Publicado: (2022)

A first-year dornase alfa treatment impact on clinical parameters of patients with cystic fibrosis: the Brazilian cystic fibrosis multicenter study
por: Rozov, Tatiana, et al.
Publicado: (2013)

Dornase alpha use in patients with cystic fibrosis
por: Marostica, Paulo José C.
Publicado: (2013)

Comparison of Normal Saline, Hypertonic Saline Albumin and Terlipressin plus Hypertonic Saline Albumin in an Infant Animal Model of Hypovolemic Shock
por: Urbano, Javier, et al.
Publicado: (2015)

Hypertonic Saline in the Treatment of Hemorrhagic Shock
por: Vahidi, Elnaz, et al.
Publicado: (2017)

Randomised controlled trial of nebulised gentamicin in children with bronchiectasis
por: Twiss, Jacob, et al.
Publicado: (2022)

3% nebulized hypertonic saline versus normal saline for infants with acute bronchiolitis: A systematic review and meta-analysis of randomized controlled trials
por: Yu, Jin-Feng, et al.
Publicado: (2022)

Randomized trial of physiotherapy and hypertonic saline techniques for sputum induction in asthmatic children and adolescents
por: Felicio-Júnior, Egberto Luiz, et al.
Publicado: (2020)

Stress ulcer prophylaxis in adult neurocritical care patients—no firm evidence for benefit or harm
por: Krag, Mette, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_qt781bocdnabpuk8nm45181mjm